AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) explained in plain language.

Never miss a new study

Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) trials appear

Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

New hope for stubborn blood disease: experimental pill enters testing

Disease control Not yet recruiting

This study is testing a pill called orelabrutinib for people with autoimmune hemolytic anemia (AIHA) whose disease has come back or hasn't responded to standard treatments. It will enroll 50 adults to find the best dose and see how well it works to control the disease over 12 to …

Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)

Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) trials appear

New hope for stubborn blood disease: experimental pill enters testing